• PL 56 (Viikinkaari 5)

    00014

    Finland

20022022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Harri Alenius

Person: Teaching and research personnel, U4 Research and teaching staff

Anu Suomalainen Wartiovaara

Person: Teaching and research personnel, U4 Research and teaching staff

Pia Siljander

Person: U3 Research and teaching staff, UH, Teaching and research personnel

Johan Lundin

Person: U4 Research and teaching staff

Kirsi Savijoki

Person: U3 Research and teaching staff, UH

Marianna Kemell

Person: U3 Research and teaching staff

L Pastore

  • Univ Napoli Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med

External person

Lucio Pastore

  • CEINGE Biotecnol Avanzate SCaRL
  • Univ Napoli Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med
  • Univ Napoli Federi, CEINGE Biotecnologie Avanzate, CEINGE Biotecnol Avanzate, Dipartimento Med Mol & Biotecnol Med
  • CEINGE-Biotecnologie Avanzate S.c.a r.l.
  • Università di Napoli Federico II

External person

Timo Joensuu

  • Docrates Canc Hosp

External person

Sara Carpi

  • Univ Pisa, University of Pisa, Dept Pharm, Mol Pharmacol Lab

External person

Raita Heiskanen

  • Oncos Therapeut Ltd

External person

Beatrice Polini

  • Univ Pisa, University of Pisa, Dept Pharm, Mol Pharmacol Lab

External person

Giorgia Oliviero

  • Univ Naples Federico 2, Dipartimento Chim Sostanze Nat
  • Univ Naples Federico II, University of Naples Federico II, Dept Mol Med & Med Biotechnol

External person

Tuuli Ranki

  • Targovax Oy
  • ValoTherapeut
  • Valo Therapeut Ltd

External person

Nicola Borbone

  • Univ Naples Federico 2, Dipartimento Chim Sostanze Nat
  • Univ Naples Federico II, University of Naples Federico II, Dept Pharm

External person

Paola Nieri

  • Univ Pisa, Dept Pharm
  • Univ Pisa, University of Pisa, Dept Pharm, Mol Pharmacol Lab

External person

Sari Pesonen

  • Targovax Oy, Dept Clin Sci
  • Valo Therapeut Ltd

External person

Matti Jalasvuori

  • University of Jyväskylä

External person

Matteo Ugolini

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Haartman Inst

External person

Gennaro Piccialli

  • Natl Res Council Italy, Inst Prot Biochem
  • Univ Naples Federico II, University of Naples Federico II, Dept Pharm

External person

Eleonora Leggiero

  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate
  • CEINGE-Biotecnologie Avanzate S.c.a r.l.

External person

Saila K. Pesonen

  • Univ Helsinki, University of Helsinki, Dept Pathol, Canc Gene Therapy Grp, Haartman Inst

External person

Ermei Mäkilä

  • University of Turku

External person

Lotta Vassilev

  • Oncos Therapeut Ltd

External person

Maria Vitale

  • ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA SICILIA
  • Univ Napoli Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med
  • Univ Napoli Federi, CEINGE Biotecnologie Avanzate, CEINGE Biotecnol Avanzate, Dipartimento Med Mol & Biotecnol Med
  • CEINGE-Biotecnologie Avanzate S.c.a r.l.
  • Università di Napoli Federico II

External person

Nicola Brunetti-Pierri

  • Yale University
  • Baylor College of Medicine

External person

Racel Cela

  • Baylor College of Medicine

External person

E. Leggiero

  • CEINGE Biotecnol Avanzate
  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate

External person

Rui M. M. Branca

  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, ICMC

External person

Leena Laasonen

  • Int Comprehens Canc Ctr Docrates

External person

Sari Pesonen

  • Targovax Oy
  • Valo Therapeut Ltd

External person

Aila Karioja-Kallio

  • Oncos Therapeut Ltd

External person

Lorella Tripodi

  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate
  • Univ Milan, CEINGE Biotecnologie Avanzate, University of Milan, CEINGE Biotecnol Avanzate, European Sch Mol Med SEMM
  • Scuola Europea di Medicina Molecolare (SEMM)

External person

Elina Haavisto

  • Oncos Therapeut Ltd

External person

Vincenzo Piccialli

  • Univ Naples Federico 2, Dipartimento Chim Organ & Biochim

External person

Ermei Mäkilä

  • Turun yliopisto

External person

Kaarina Partanen

  • Int Comprehens Canc Ctr Docrates

External person

Antonella Romanini

  • Univ Hosp Pisa, University of Pisa, Azienda Ospedaliero Universitaria Pisana, Oncol Sect
  • Azienda Osped Univ Pisana, University of Pisa, Azienda Ospedaliero Universitaria Pisana, Med Oncol Unit
  • Univ Hosp Pisa, University of Pisa, Azienda Ospedaliero Universitaria Pisana, Med Oncol Unit

External person

Luigi Buonaguro

  • Ist Nazl Tumori IRCCS G Pascale, IRCCS Fondazione Pascale, Canc Immunoregulatory
  • Fdn Pascale IRCCS, IRCCS Fondazione Pascale, Innovat Immunol Models, Ist Nazl Studio & Cura Tumori

External person

Elina Haavisto

  • HUSLAB
  • University of Turku

External person

Masataka Suzuki

  • Baylor College of Medicine

External person

Sabrina Zaccaria

  • Univ Naples Federico 2, Dipartimento Chim Organ & Biochim

External person

Yvonne Giannoula

  • Univ Helsinki, University of Helsinki, Translat Immunol Res Program, TRIMM
  • Univ Helsinki, University of Helsinki, Drug Res Program, Lab Immunovirotherapy, Fac Pharm

External person

Laura Denby

  • University of Glasgow

External person

Jonas Buck

  • University of Basel

External person

Elina Haavisto

  • Oncos Therapeutics Oy
  • University of Turku
  • Satakunta Hosp Dist

External person

B. Lee

  • Hanyang Univ, Hanyang University

External person

Brendan Lee

  • Yale University
  • Baylor College of Medicine

External person

Valeria D'Argenio

  • Univ Telemat Sa, CEINGE Biotecnologie Avanzate, CEINGE Biotecnol Avanzate, Dipartimento Promoz Sci Umane & Qual Vita
  • CEINGE-Biotecnologie Avanzate S.c.a r.l.
  • Università Telematica San Raffaele

External person

Siri Tahtinen

  • Univ Helsinki, University of Helsinki, Canc Gene Therapy Grp, Dept Pathol & Transplantat Lab, Haartman Inst

External person

Anne-Sophie W. Moller

  • Targovax ASA, Dept Clin Sci
  • University of Copenhagen

External person

Antonio Federico

  • Univ Siena, Sect Neurol Sci, Dept Neurol Neurosurg & Behav Sci
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Hlth Technol, Allergy Ctr
  • Univ Tampere, Tampere University, BioMediTech Inst, Fac Med & Life Sci
  • Tampere Univ, Tampere University, Prof Dario Grecos Grp
  • Tampere Univ, Tampere University, Finnish Hub Dev & Validat Integrated Approaches F
  • Tampere University
  • Tampere Univ, Tampere University, Fac Med & Hlth Technol, Finnish Hub Dev & Validat Integrated Approaches F
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol

External person

Andreas Helminen

  • Int Comprehens Canc Ctr Docrates

External person

Lotta Vassilev

  • University of Helsinki, Helsinki
  • Targovax Oy

External person

Roberto Centore

  • Univ Naples Federico 2, Dipartimento Chim

External person

Andrew H. Baker

  • University of Glasgow

External person

Leena Laasonen

  • Docrates Canc Ctr

External person

L. Pastore

  • CEINGE Biotecnol Avanzate
  • Univ Helsinki, University of Helsinki, Inst Mol Med Finland, FIMM, Helsinki Inst Life Sci HiLIFE

External person

Dmitrii Romaniuk

  • University of Helsinki, Helsinki
  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

Mari Madetoja

  • Made Consulting

External person

Jarno Salonen

  • Turun yliopisto

External person

Brendan Lee

  • Baylor College of Medicine

External person

Aila Karioja-Kallio

  • Univ Helsinki, Canc Gene Therapy Grp, Transplantat Lab, Haartman Inst

External person

Matteo Ugolini

  • Univ Helsinki, Canc Gene Therapy Grp

External person

Eerika Karli

  • Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp

External person

Stefano D'Errico

  • Univ Naples Federico 2, Dipartimento Chim Sostanze Nat

External person

Tuomo Alanko

  • Int Comprehens Canc Ctr Docrates

External person

Alessandra Lopes

  • Universite catholique de Louvain

External person

Terry K. Bertin

  • Baylor College of Medicine

External person

Teea Sarvela

  • University of Helsinki, Helsinki
  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

Janne Lehtiö

  • Karolinska Institutet

External person

Gianpietro Dotti

  • Baylor College of Medicine

External person

Kalevi Kairemo

  • Int Comprehens Canc Ctr Docrates

External person

A. Vitale

  • Univ Napoli Parthenope, Parthenope University Naples, Consorzio CREATE

External person

Sandro Sieber

  • University of Basel

External person

Lukasz Kuryk

  • Targovax Oy
  • Targovax Oy, R&D, Clin Sci

External person

Gaëlle Vandermeulen

  • Universite catholique de Louvain

External person

Fabrice Le Boeuf

  • Ottawa Hlth Res Inst, Ctr Canc Therapeut

External person

Christianne Groeneveldt

  • Leiden Univ, Leiden University, Fac Sci, Translat Epidemiol

External person

P. Ciana

  • Univ Milan, University of Milan, Ctr Excellence Neurodegenerat Dis, Dept Oncol & Hemato Oncol

External person

Angela Tuzi

  • Univ Naples Federico 2, Dipartimento Chim

External person

John R. Rodgers

  • Baylor College of Medicine

External person

Barbara Szomolay

  • Imperial College London
  • Cardiff Univ, Cardiff University, Sch Med, Inst Med Genet

External person

B. Lombardo

  • CEINGE Biotecnol Avanzate

External person

Elina Haavisto

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Haartman Inst
  • TILT Biotherapeut Ltd

External person

Luciano Mayol

  • Univ Naples Federico II, University of Naples Federico II, Dipartimento Farm

External person

Antti Vuolanto

  • Oncos Therapeutics Oy
  • Herantis Pharma Plc

External person

G. Iaccarino

  • Univ Salerno, University of Salerno, Lab Mol Med & Genom, Dept Med & Surg

External person

Aila Karioja-Kallio

  • University of Helsinki, Helsinki

External person

Marko Ahonen

  • University of Helsinki

External person

Katariina Koskinen

  • University of Jyväskylä

External person

M. A. Villa

  • Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Trasfus & Immunoematol
  • Univ Milan, University of Milan, Ctr Excellence Neurodegenerat Dis, Dept Oncol & Hemato Oncol

External person

Paul E. Brown

  • Monash University

External person

Jeanette H.W. Leusen

  • Utrecht University Medical Center

External person

Martin Muller

  • Ludwig Maximilians Univ Munchen LMU Munchin

External person

Lucia Sacchetti

  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate

External person

Daniela Marzioni

  • Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies

External person

Giorgia Oliviero

  • Univ Naples Federico II, University of Naples Federico II, Dipartimento Farm

External person

Matteo Ugolini

  • Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp

External person

A. Ranieri

  • Politecn Bari, Politecnico di Bari, Dipartimento Ingn Elettr & Informaz

External person

Gerd Bauerschmitz

  • Univ Helsinki, Canc Gene Therapy Grp, Transplantat Lab

External person

Yu Zuo

  • Baylor College of Medicine

External person

Aila Karioja-Kallio

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Haartman Inst

External person

Adrienne C. Dow

  • University of California Los Angeles

External person

Ervin Tasnadi

  • Hungarian Acad Sci, Hungarian Academy of Sciences, Biol Res Ctr, Synthet & Syst Biol Unit
  • Hungarian Acad Sci, Hungarian Academy of Sciences, BRC, Synthet & Syst Biol Unit
  • Univ Szeged, Szeged University, Doctoral Sch Comp Sci
  • Eotvos Lorand Res Network, Hungarian Academy of Sciences, Hungarian Biological Research Center, Synthet & Syst Biol Unit, Biol Res Ctr

External person

Xiao-Jiang Li

  • Emory Univ, Emory University, Sch Med, Dept Human Genet

External person

G. Iaccarino

  • Univ Salerno, University of Salerno, Chair Psychiat

External person

Kaarina P. L. Partanen

  • Int Comprehens Canc Ctr Docrates

External person

Timo Joensuu

  • Int Comprehens Canc Ctr Docrates
  • Docrates Hosp

External person

John R. McGuire

  • Emory Univ, Emory University, Sch Med, Dept Human Genet

External person

Johann Foloppe

  • Transgene SA

External person

O. H. Grohn

  • University of Eastern Finland (UEF)

External person

Robert Tallberg

  • Univ Helsinki, University of Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Programme

External person

M. R. Guarracino

  • Natl Res Council Italy, Consiglio Nazionale delle Ricerche (CNR), High Performance Comp & Networking Inst

External person

Donna Palmer

  • Baylor College of Medicine

External person

Jarno Salonen

  • University of Turku

External person

Adriano Podesta

  • Univ Pisa, University of Pisa, Vet Teaching Hosp, Dept Vet Sci

External person

Justin Livesay

  • University of California Los Angeles

External person

Vladia Monsurro

  • Univ Verona, Sch Med, Dept Pathol

External person

J. Narvainen

  • University of Eastern Finland (UEF)

External person

Magnus Jaderberg

  • Oncos Therapeutics Oy
  • Targovax ASA, Dept Clin Sci

External person

Dario Greco

  • Faculty of Medicine and Health Technology, Tampere University

External person

Shi-Hua Li

  • Emory Univ, Emory University, Sch Med, Dept Human Genet

External person

Nathan C. Grove

  • Baylor College of Medicine

External person

Valentina Citi

  • Univ Pisa, University of Pisa, Dept Pharm, Mol Pharmacol Lab

External person

Ulrike Gerdemann

  • Baylor College of Medicine

External person

Paivi Hannuksela

  • Univ Helsinki, Canc Gene Therapy Grp, Transplantat Lab

External person

Saila Pesonen

  • Univ Helsinki, University of Helsinki, Canc Gene Therapy Grp, Dept Pathol & Transplantat Lab, Haartman Inst
  • Finnish Inst Occupat Hlth, Finnish Institute of Occupational Health, ICT & Digital Serv

External person

Ramon Alemany

  • IDIBELL, Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Catalan Institute of Oncology, University of Barcelona, Inst Catala Oncol, Hereditary Canc Program

External person

Chia-Ling Gau

  • University of California Los Angeles

External person

Gerd J. Bauerschmitz

  • Univ Helsinki, Transplantat Lab

External person

Monika Lusky

  • Transgene SA

External person

Nobuhiro Nishio

  • Baylor College of Medicine

External person

E. Haavisto

  • Univ Helsinki, Transplantat Lab, Haartman Inst, Canc Gene Therapy Grp

External person

Hanne Cojoc

  • Valo Therapeut Ltd

External person

Jose-Maria Gonzalez-Granado

  • Univ Autonoma Madrid UAM, Fac Med, Dept Fisiol

External person

Henrik Paavilainen

  • University of Turku

External person

Satu Kauppinen

  • Int Comprehens Canc Ctr Docrates

External person

T. Whalley

  • Cardiff Univ, Cardiff University, Sch Med, Inst Med Genet

External person

Erika Espo

  • Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki

External person

Donatella Montanaro

  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate

External person

I. Granata

  • Natl Res Council Italy, Consiglio Nazionale delle Ricerche (CNR), High Performance Comp & Networking Inst

External person

Valentina Romano

  • Univ Helsinki, Dept Mol Canc Biol, Biomedicum

External person

Petra Ahokas

  • Valo Therapeut Ltd

External person

Chuan-En Wang

  • Emory Univ, Emory University, Sch Med, Dept Human Genet

External person

Giulia Scalia

  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate

External person

Beate Rinner

  • Medical University Graz
  • Med Univ Graz, Medical University of Graz, Core Facil Alternat Biomodels & Preclin Imaging, Biomed Res

External person

G. Bauerschmitz

  • Univ Helsinki, Transplantat Lab, Haartman Inst, Canc Gene Therapy Grp

External person

Cristina Mirantes

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Mol Canc Biol Program,Haartman Inst

External person

Jun Teruya

  • Texas Childrens Hosp, Baylor College of Medicine, Special Coagulat Lab

External person

Cristina Malorzo

  • Univ Helsinki, University of Helsinki, Drug Res Program, Lab Immunovirotherapy, Fac Pharm

External person

Pia Anneli Sofia Kinaret

  • Faculty of Medicine and Health Technology, Tampere University

External person

Kathryn Ottolino-Perry

  • Toronto Gen Res Inst

External person

Paolo Ciana

  • Univ Milan, University of Milan, Ctr Excellence Neurodegenerat Dis, Dept Oncol & Hematooncol

External person

Marco Colombatti

  • Univ Integrata Verona, Aziendaosped

External person

Ruben Hernandez-Alcoceba

  • Univ Navarra, Ctr Appl Med Res, Gene Therapy Unit

External person

Philip Ng

  • Baylor College of Medicine

External person

Julia Karbach

  • Krankenhaus NW Frankfurt, Hamatol Onkol
  • Krankenhaus NW Frankfurt, Krankenhaus Nordwest, Dept Oncol & Hematol

External person

John C. Bell

  • Ottawa Hlth Res Inst, Ctr Canc Therapeut

External person

Maria Marzano

  • Univ Naples Federico II, University of Naples Federico II, Dept Pharm

External person

A. Karttunen

  • Univ Helsinki, University of Helsinki, Haartman Inst, Dept Pathol & Transplantat Lab, Canc Gene Therapy Grp

External person

Claudia De Lorenzo

  • CEINGE-Biotecnologie Avanzate S.c.a r.l.
  • Università di Napoli Federico II

External person

A. Serafin

  • Univ Bologna, University of Bologna, Fac Pharm

External person

P. Soininen

  • University of Eastern Finland (UEF)

External person

Luca Cattelani

  • Univ Tampere, Tampere University, BioMediTech Inst, Fac Med & Life Sci
  • Tampere Univ, Tampere University, Fac Med & Hlth Technol, Finnish Hub Dev & Validat Integrated Approaches F

External person

Stefano D'Errico

  • Univ Naples Federico II, University of Naples Federico II, Dipartimento Farm

External person

Tiina Hakonen

  • Oncos Therapeut Ltd

External person

Jarno Salonen

  • Harvard University
  • University of Turku

External person

Sara Feolaf

  • University Federico II Naples

External person

A. D'Agostino

  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate

External person

Paivi Hannuksela

  • Univ Helsinki, Canc Gene Therapy Grp, Transplantat Lab, Haartman Inst

External person

Paola Salvatore

  • CEINGE-Biotecnologie Avanzate S.c.a r.l.
  • Università di Napoli Federico II

External person

Alfredo Budillon

  • Fdn G Pascale IRCCS, Fondazione IRCCS Istituto Nazionale Tumori Milan, Ist Nazl Tumori, Expt Pharmacol

External person

Laura Aliisa Saarimaki

  • Univ Tampere, Tampere University, BioMediTech Inst, Fac Med & Life Sci
  • Tampere Univ, Tampere University, Fac Med & Hlth Technol, Finnish Hub Dev & Validat Integrated Approaches F

External person

M. Passariello

  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate
  • INNOVA SCaRL

External person

Seppo Ylä-Herttuala

  • Kuopio University Hospital (KYS)
  • University of Eastern Finland (UEF)
  • University of Eastern Finland

External person

Hui Zhou

  • Emory Univ, Emory University, Sch Med, Dept Human Genet

External person

M. Medeot

  • Univ Padua, University of Padua, Dept Pharmaceut & Pharmacol Sci

External person

Tiia Turunen

  • University of Eastern Finland (UEF)

External person

Oona Honkasalo

  • Univ Helsinki, University of Helsinki, Drug Res Program, Lab Immunovirotherapy, Fac Pharm

External person

Janne Lehtio

  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, Dept Clin Neurosci, Div Psychol

External person

Fides D. Lay

  • University of California Los Angeles

External person

Ann M. Leen

  • Baylor College of Medicine

External person

Elina Haavisto

  • Univ Helsinki, Canc Gene Therapy Grp, Transplantat Lab, Haartman Inst

External person

A. Helminen

  • Univ Helsinki, Transplantat Lab, Haartman Inst, Canc Gene Therapy Grp

External person

Lotta Vassilev

  • Univ Helsinki, University of Helsinki, Dept Pathol, Fac Med, Canc Gene Therapy Grp

External person

Juan Rojas

  • IDIBELL Inst Catala Oncol, Translat Res Lab

External person

Vincenzo Mazzaferro

  • Ist Nazl Tumori Fdn IRCCS, Fondazione IRCCS Istituto Nazionale Tumori Milan, Natl Canc Inst
  • Fdn IRCCS Ist Nazl Tumori, Fondazione IRCCS Istituto Nazionale Tumori Milan, Natl Canc Inst Milan, Dept Surg Transplantat & Hepatobiliary, Canc Unit
  • Univ Milan, University of Milan, Ctr Excellence Neurodegenerat Dis, Dept Oncol & Hematooncol

External person

Gautam Sule

  • Baylor College of Medicine

External person

Jarno Salonen

  • University of Turku

External person

Dario Fiorenza

  • IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)

External person

Alfonso Baldi

  • Univ Campania Luigi Vanvitelli, Universita della Campania Vanvitelli, Dept Environm Biol & Pharmaceut Sci & Technol

External person

R. Immonen

  • University of Eastern Finland (UEF)

External person

C. Clarke

  • Wayne State University

External person

Sirkka-Liisa Holm

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Haartman Inst

External person

Barbara Savoldo

  • Baylor College of Medicine
  • Texas Childrens Hosp, Baylor College of Medicine, Dept Pediat

External person

Seppo Yla-Herttuala

  • Turku University Hospital
  • University of Eastern Finland (UEF)

External person

Christian Celia

  • University ‘‘G. d’Annunzio’’ of Chieti-Pescara, Chieti, Italy

External person

Johanna K. Kaufmann

  • German Canc Res Ctr, DKFZ, Oncolyt Adenovirus Grp

External person

Arttu Uoti

  • Univ Helsinki, University of Helsinki, Translat Immunol Res Program, TRIMM

External person

Maria Tagliamonte

  • Ist Nazl Tumori IRCCS G Pascale, IRCCS Fondazione Pascale, Canc Immunoregulatory

External person

Petri Priha

  • Oncos Therapeutics Oy
  • Valo Therapeut Ltd

External person

S. Hemmi

  • Univ Zurich, Inst Mol Biol

External person

Antti Vuolanto

  • TKK
  • Targovax Oy

External person

Marta Sloniecka

  • Univ Helsinki, Haartman Inst

External person

Andreas Helminen

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Haartman Inst

External person

S. Carpi

  • Univ Pisa, University of Pisa, Istituto Nazionale di Fisica Nucleare, Dept Pharm

External person

Giusy del Giudice

  • Univ Tampere, Tampere University, BioMediTech Inst, Fac Med & Life Sci
  • Tampere Univ, Tampere University, Prof Dario Grecos Grp
  • Tampere Univ, Tampere University, Fac Med & Hlth Technol, Finnish Hub Dev & Validat Integrated Approaches F
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol

External person

Tambet Teesalu

  • Univ Calif Santa Barbara, University of California Santa Barbara, University of California System, Ctr Nanomed, Sanford Burnham Prebys Med Discovery Inst
  • Univ Calif Santa Barbara, University of California System, University of California Santa Barbara, Dept Mol Cellular & Dev Biol
  • Univ Tartu, University of Tartu, Inst Biomed & Translat Med, Canc Biol Lab

External person

Thomas Whalley

  • Cardiff Univ, Cardiff University, Sch Med, Inst Med Genet

External person

J. Paasonen

  • University of Eastern Finland (UEF)

External person

F. Salvatore

  • CEINGE Biotecnol Avanzate

External person

G. Labruna

  • Fdn IRCCS SDN, Ist Ric Diagnost & Nucl

External person

D. Astone

  • CEINGE Biotecnol Avanzate

External person

K. Partanen

  • Docrates Canc Ctr, Helsinki

External person

Uma Thanigai Arasu

  • University of Eastern Finland, Kuopio

External person

Ramon Alemany

  • IDIBELL Inst Catala Oncol, Translat Res Lab

External person

Michele Fratello

  • Univ Tampere, Tampere University, BioMediTech Inst, Fac Med & Life Sci
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol
  • Tampere Univ, Tampere University, Fac Med & Hlth Technol, Finnish Hub Dev & Validat Integrated Approaches F

External person

Giuseppe Labruna

  • IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)

External person

Margherita Passariello

  • CEINGE-Biotecnologie Avanzate S.c.a r.l.

External person

Pamela Osterlund

  • National Institute for Health and Welfare (THL)
  • Natl Inst Hlth & Welf, Finland National Institute for Health & Welfare, Dept Hlth Secur, Expert Microbiol Unit

External person

Timo Joensuu

  • Docrates Canc Ctr, Helsinki

External person

Mauri Kostiainen

  • Aalto University

External person

Christian Clarke

  • Baylor College of Medicine

External person

Chiara Di Lorenzo

  • Univ Napoli Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med

External person

K. T. Jokivarsi

  • University of Eastern Finland (UEF)

External person

Calvin Ng

  • Toronto Gen Res Inst

External person

Georgios Mermelekas

  • Karolinska Institutet

External person

Stephen D. Cederbaum

  • University of California Los Angeles

External person

Ville Veckman

  • Finnish Institute of Occupational Health (TTL)

External person

Sirkka-Liisa Holm

  • Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp

External person

Alma Martelli

  • Univ Pisa, University of Pisa, Dept Pharm, Mol Pharmacol Lab

External person

M. Lappalainen

  • Univ Helsinki, Cent Hosp, Lab Div

External person

Dirk M. Nettelbeck

  • German Canc Res Ctr, DKFZ, Oncolyt Adenovirus Grp

External person

Adelaide Greco

  • Ist Biostrutture & Bioimmagini, Consiglio Nazionale delle Ricerche (CNR), Istituto di Biostrutture e Bioimmagini (IBB-CNR), Sede Secondaria Catania

External person

L. Tripodi

  • CEINGE Biotecnol Avanzate, CEINGE Biotecnologie Avanzate

External person

Saila Pesonen

  • Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp

External person

Eerika Karli

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Haartman Inst

External person

Veijo Hukkanen

  • University of Turku

External person

Leena Ylösmäki

  • Valo Therapeut Ltd

External person

Saila Pesonen

  • Univ Helsinki, University of Helsinki, Canc Gene Therapy Grp, Dept Pathol

External person

Brad Spiller

  • Cardiff Univ, Sch Med, Dept Child Hlth

External person

Filippo Maria Santorelli

  • IRCCS Stella Maris, Mol Med
  • IRCCS Fdn Stella Maris, IRCCS Fondazione Stella Maris, Med Mol
  • IRCCS Stella Maris Fdn, IRCCS Fondazione Stella Maris, Mol Med Neurodegenerat & Neuromuscular Dis Unit

External person

Mariangela Garofalo

  • Univ Naples Federico II, University of Naples Federico II, Dept Mol Med & Med Biotechnol

External person

Rachel Edwards

  • Texas Childrens Hosp, Baylor College of Medicine, Special Coagulat Lab

External person

M. Croyle

  • Univ Texas Austin, University of Texas Austin, Coll Pharm, Div Pharmaceut

External person

Mikko Turunen

  • University of Helsinki
  • University of Eastern Finland (UEF)

External person

Gerd J. Bauerschmitz

  • Univ Dusseldorf, Heinrich Heine University Dusseldorf, Univ Hosp Dseeldorf, Dept Gynecol & Obstet

External person

Nicola Borbone

  • Univ Naples Federico II, University of Naples Federico II, Dipartimento Farm

External person

Antonio di Lieto

  • Department of Forensic Psychiatry, Aarhus University
  • Aarhus University Hospital

External person

Saila K. Pesonen

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Haartman Inst

External person

Victor Cervera-Carascon

  • Univ. Helsinki, Techn. Univ. Helsinki

External person

Husen M. Umer

  • Karolinska Institutet

External person

Gerald S. Lipshutz

  • University of California Los Angeles

External person

Stefano Fogli

  • Univ Pisa, University of Pisa, Dept Clin & Expt Med

External person

Magnus Jaderberg

  • Oncos Therapeut
  • Targovax ASA, Dept Clin Sci

External person

S. Parvianen

  • Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Helsinki ; Univ Helsinki, Haartman Inst, Helsinki, Finland

External person

Angela Serra

  • Univ Salerno, University of Salerno, DISA MIS, NeuRoNeLab
  • Tampere University Hospital (TAYS)
  • Univ Tampere, Tampere University, BioMediTech Inst, Fac Med & Life Sci
  • Tampere Univ Technol, Tampere University, Inst Biosci & Med Technol, BioMediTech, Dept Elect & Commun Engn
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Hlth Technol, Allergy Ctr
  • Tampere Univ, Tampere University, Prof Dario Grecos Grp
  • Tampere Univ, Tampere University, Fac Med & Hlth Technol, Finnish Hub Dev & Validat Integrated Approaches F
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol

External person

Fabrizia Nici

  • Univ Naples Federico II, University of Naples Federico II, Dipartimento Farm

External person

Eliana Ruggiero

  • IRCCS San Raffaele, IRCCS Ospedale San Raffaele, IRCCS San Raffaele Pisana, Dept Med Sci

External person

Robin A. Rosenblatt

  • University of California Los Angeles

External person

Dung-Tsa Chen

  • University of South Florida

External person

Paivi Hannuksela

  • Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp

External person

Gerd J. Bauerschmitz

  • Univ Dusseldorf, Dept Obstet & Gynecol

External person

Wayne W. Grody

  • University of California Los Angeles

External person

Aila Karioja-Kallio

  • Oncos Therapeutics Oy

External person

Laura Gentile

  • Univ Napoli Federi, CEINGE Biotecnologie Avanzate, CEINGE Biotecnol Avanzate, Dipartimento Med Mol & Biotecnol Med

External person

Barbara Lombardo

  • Univ Napoli Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med

External person

Beatriz Martins

  • Univ Helsinki, University of Helsinki, Res Programmes Unit, Genome Scale Biol, Biomedicum Helsinki
  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

Roberta Colicchio

  • Università di Napoli Federico II

External person

Matteo Gramanzini

  • Ist Biostrutture & Bioimmagini, Consiglio Nazionale delle Ricerche (CNR), Istituto di Biostrutture e Bioimmagini (IBB-CNR), Sede Secondaria Catania

External person

Kalevi Kairemo

  • Docrates Canc Ctr

External person

Hao Liu

  • Baylor College of Medicine

External person

Petri Nokisalmi

  • Univ Helsinki, Canc Gene Therapy Grp

External person

Matthew J. Vaughan

  • Valo Therapeut Ltd

External person

Daniela Crescenti

  • Univ Milan, University of Milan, Ctr Excellence Neurodegenerat Dis, Dept Oncol & Hematooncol

External person

Andrea Vitale

  • University of Naples Parthenope

External person

Elena Celi

  • University ‘‘G. d’Annunzio’’ of Chieti-Pescara, Chieti, Italy

External person

N. Rizzi

  • Univ Milan, University of Milan, Ctr Excellence Neurodegenerat Dis, Dept Oncol & Hematooncol
  • Nagoya Univ, Nagoya University, Inst Adv Res

External person

A. Karioja-Kallio

  • Univ Helsinki, Transplantat Lab, Haartman Inst, Canc Gene Therapy Grp

External person

Chiara Bonini

  • IRCCS San Raffaele, IRCCS Ospedale San Raffaele, IRCCS San Raffaele Pisana, Dept Med Sci

External person

J. Andrea McCart

  • Toronto Gen Res Inst

External person

Valentina Romano

  • Univ Helsinki, Canc Gene Therapy Grp, Transplantat Lab, Haartman Inst

External person

Ronen Alon

  • Weizmann Inst Sci, Weizmann Institute of Science, Dept Immunol
  • Weizmann Inst Sci, Weizmann Institute of Science

External person

L. Sacchetti

  • CEINGE Biotecnol Avanzate

External person

Hongbo Zhang

  • Åbo Akademi och Åbo universitet

External person

R. A. Desmond

  • Univ Alabama, Ctr Comprehens Canc, Biostat & Bioinformat Unit

External person

Manel Cascallo

  • IDIBELL Inst Catala Oncol, Translat Res Lab

External person

Saila K. Pesonen

  • Helsingin yliopisto, Lääketieteellinen tiedekunta

External person

Valentina Hoyos

  • Baylor College of Medicine

External person

Sampsa Matikainen

  • Finnish Institute of Occupational Health (TTL)

External person

Alisa Pavel

  • Faculty of Medicine and Health Technology, Tampere University
  • Tampere Univ, Tampere University, Prof Dario Grecos Grp
  • Tampere Univ, Tampere University, Fac Med & Hlth Technol, Finnish Hub Dev & Validat Integrated Approaches F
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol

External person

Elena Di Gennaro

  • Fdn G Pascale IRCCS, Fondazione IRCCS Istituto Nazionale Tumori Milan, Ist Nazl Tumori, Expt Pharmacol

External person

G. Bauerschmitz

  • Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program

External person

Mikko Savontaus

  • University of Turku
  • Univ Turku, University of Turku, MedCity Res Lab
  • Univ Turku, University of Turku, Turku BioImaging

External person

V. D'Argenio

  • Univ Napoli Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med

External person

Tuula A. Nyman

  • Institute of Clinical Medicine, Department of Immunology, Faculty of Medicine, Rikshospitalet, University of Oslo & Oslo University Hospital

External person

Vincenzo Piccialli

  • Univ Naples Federico II, University of Naples Federico II, Dipartimento Sci Chim

External person

Kilian Guse

  • University of Helsnki

External person

H. Yli-Ollila

  • University of Eastern Finland (UEF)

External person

Stefano Doccini

  • Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Stella Maris Foundation, Pisa
  • IRCCS Stella Maris Fdn, IRCCS Fondazione Stella Maris, Mol Med Neurodegenerat & Neuromuscular Dis Unit

External person

Andrea Ilaria Zotti

  • Fdn G Pascale IRCCS, Fondazione IRCCS Istituto Nazionale Tumori Milan, Ist Nazl Tumori, Expt Pharmacol

External person

Tima Joensuu

  • Int Comprehens Canc Ctr Docrates

External person

C. Mazzaccara

  • Univ Naples Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med

External person

Philippe Erbs

  • Transgene SA

External person

Paivi Hannuksela

  • Univ Helsinki, Canc Gene Therapy Grp, Transplantat Lab, Haartman Inst,Biomedicum

External person

F. Frascaro

  • Univ Siena, University of Siena

External person

Margaretha Guenther

  • Baylor College of Medicine

External person

Ignazio Caruana

  • Baylor College of Medicine

External person

Marta Sloniecka

  • Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program

External person

Elke Jäger

  • Krankenhaus NW Frankfurt, Krankenhaus Nordwest, Dept Oncol & Hematol

External person

Marta Medeot

  • Univ Padua, University of Padua, Dept Pharmaceut & Pharmacol Sci

External person

Kaarina Partanen

  • Docrates Canc Ctr

External person

Nan Tang

  • Toronto Gen Res Inst

External person

E. Karli

  • Univ Helsinki, Transplantat Lab, Haartman Inst, Canc Gene Therapy Grp

External person

Lisa Bouchier-Hayes

  • Texas Childrens Hosp, Baylor College of Medicine, Dept Pediat

External person

Reidar Grenman

  • University of Turku
  • Turku University Hospital

External person

Andrea Patrizia Falanga

  • Univ Naples Federico II, University of Naples Federico II, Dept Pharm

External person

Andre Lieber

  • University of Washington Seattle
  • University of Washington

External person

Laura Iaffaldano

  • Univ Napoli Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med

External person

Onerva Levälampi

  • University of Helsinki, Helsinki

External person